Mounjaro Tirzepatide GIP() + GLP-1 (-1) GIP GLP-1 SURMOUNT-1 DEXA Mounjaro (5 mg10 mg 15 mg) 72 DEXA = dual-energy X-ray absorptiometry
Taking two doses within 48 hours increases the risk of dose-stacking side effects such as severe nausea, vomiting, or diarrhea without improving therapeutic benefit
This activity supports cell signaling, promotes cellular repair, and contributes to healthy tissue function, key elements in skin rejuvenation and anti-aging
D., Hoerler-Koerner, U., Bodmer, M.,
This FDA-approved treatment is designed to support weight loss by helping to control appetite and improve metabolism
10,11 California's spending on the three drugs approved for the weight loss indication increased fourfold from early 2024 to mid 2025, as outlined in Figure 2